Alan Grujic - 21 Aug 2025 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Role
Director
Signature
/s/ Alan Grujic
Issuer symbol
GTHP
Transactions as of
21 Aug 2025
Transactions value $
$0
Form type
4
Filing time
05 Sep 2025, 16:25:49 UTC
Previous filing
12 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Grujic Alan Director 5835 PEACHTREE CORNERS EAST, SUITE B, PEACHTREE CORNERS /s/ Alan Grujic 04 Sep 2025 0001980904

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHP Common Stock Other +17.4K +1.2% 1.47M 21 Aug 2025 Direct F1
transaction GTHP Preferred Series E Stock Other -50 -100% 0 21 Aug 2025 Direct F2
transaction GTHP Common Stock Other +200K +13.65% 1.67M 21 Aug 2025 Direct F2
transaction GTHP Common Stock Purchase +152K +9.13% 1.82M 29 Aug 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHP Warrants Purchase +152K +608.43% 177K 29 Aug 2025 Common Stock 152K $0.25 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.
F2 On August 21, 2025, Mr. Grujic converted 50 shares of Series E preferred stock into 200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.
F3 On August 29, 2025, the Company closed on Tranche 4 Private Financing. The Company simultaneously entered into a Securities Purchase Agreement and an exchange agreement with Mr. Grujic, whereby Mr. Grujic agreed to exchange a $25,000 note payable and accrued interest of $2,379.45 for an aggregate of 152,108 units, each unit consisting of one share of common stock and one warrant to purchase up to 152,108 shares of common stock (the "August Warrants"). The August Warrants were immediately exercisable upon issuance and will expire in four years following the issuance date and have an exercise price of $0.25 per share.